Evidence map›Paper›PMID 30707691›Full record

ArticlePloS one2019

Controlling the dynamics of the Nek2 leucine zipper by engineering of "kinetic" disulphide bonds.

Daniel S Gutmans, Sara B-M Whittaker, Karishma Asiani, R Andrew Atkinson, Alain Oregioni, Mark Pfuhl

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel S GutmansRandall Centre and School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingodm.ORCID 0000-0003-1165-538X
Sara B-M WhittakerThe Henry Wellcome Building for Biomolecular NMR Spectroscopy, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingodm.
Karishma AsianiRandall Centre and School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingodm.
R Andrew AtkinsonRandall Centre and School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingodm.
Alain OregioniMedical Research Council (MRC) Biomolecular NMR Centre, The Francis Crick Institute, London, United Kingdom.
Mark PfuhlRandall Centre and School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingodm.ORCID 0000-0001-9592-6639
King's College London · GBThe Francis Crick Institute · GBUniversity of Birmingham · GB

Funding

Medical Research Council MC_U117533887
6 · The paper itself

Abstract

Nek2 is a dimeric serine/ threonine protein kinase that belongs to the family of NIMA-related kinases (Neks). Its N-terminal catalytic domain and its C-terminal regulatory region are bridged by a leucine zipper, which plays an important role in the activation of Nek2's catalytic activity. Unusual conformational dynamics on the intermediary/slow timescale has thwarted all attempts so far to determine the structure of the Nek2 leucine zipper by means of X-ray crystallography and Nuclear Magnetic Resonance (NMR). Disulfide engineering, the strategic placement of non-native disulfide bonds into flexible regions flanking the coiled coil, was used to modulate the conformational exchange dynamics of this important dimerization domain. The resulting reduction in exchange rate leads to substantial improvements of important features in NMR spectra, such as line width, coherence transfer leakage and relaxation. These effects were comprehensively analyzed for the wild type protein, two single disulfide bond-bearing mutants and another double disulfide bonds-carrying mutant. Furthermore, exchange kinetics were measured across a wide temperature range, allowing for a detailed analysis of activation energy (ΔG‡) and maximal rate constant (k'ex). For one mutant carrying a disulfide bond at its C-terminus, a full backbone NMR assignment could be obtained for both conformers, demonstrating the benefits of the disulfide engineering. Our study demonstrates the first successful application of 'kinetic' disulfide bonds for the purpose of controlling the adverse effects of protein dynamics. Firstly, this provides a promising, robust platform for the full structural and functional investigation of the Nek2 leucine zipper in the future. Secondly, this work broadens the toolbox of protein engineering by disulfide bonds through the addition of a kinetic option in addition to the well-established thermodynamic uses of disulfide bonds.

Indexed as

Amino Acid SubstitutionLeucine ZippersCrystallography, X-RayDisulfidesHumansNIMA-Related KinasesNuclear Magnetic Resonance, BiomolecularDisulfidesNEK2 protein, humanNIMA-Related Kinases

Identifiers

PMID30707691
PMCPMC6358272
OpenAlexW2911619300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.